Linked Life Data

20214431

Source:http://linkedlifedata.com/resource/pubmed/id/20214431

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2010-3-10
pubmed:abstractText
Proton radiation therapy has been available for decades. However, until recently it was only applied to a small number of patients at approximately 20 centers worldwide. Increased clinical experience with protons, as well as extensive research in the physics, biology and clinical aspects of proton therapy, have recently led to a huge interest in proton therapy among radiation oncologists. In addition, the cost for facilities is expected to decrease. Many proton therapy facilities are currently being built and planned worldwide. It is expected that the number of patients treated with protons will increase substantially in the near future. This article summarizes the rationale for (proton) radiation therapy and addresses the promises and challenges of proton-beam therapy in the management of localized cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1745-2422
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
275-85
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Proton radiation in the management of localized cancer.
pubmed:affiliation
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. h.paganetti@partners.org
pubmed:publicationType
Journal Article, Review